Therapeutic Innovation Australia is a national consortium of translational research infrastructure. 
Through TIA, Australian researchers from the public and private sector can access a range of expertise and services to assist in the development of new therapeutic products.
The TIA Consortium includes national and international expertise in the development of small molecule pharmaceuticals, biologics & vaccines and cell & gene therapies.

29 April 2021




TIA announces investment in Protein Expression Facility (PEF), the nucleic acids facility at AIBN, UQ

TIA is excited to announce the investment in PEF to support the development of nucleic acids (RNA and DNA) for research and development.